Remyelinating strategies for the treatment of multiple sclerosis.
about
Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerateNonmuscle myosin-2: mix and matchThyroid hormone administration enhances remyelination in chronic demyelinating inflammatory diseaseIn vivo quantification of myelin changes in the vertebrate nervous system.Peripheral axons of the adult zebrafish maxillary barbel extensively remyelinate during sensory appendage regeneration.Imaging of CNS myelin by positron-emission tomography.Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination.Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans.Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies.Transplantation of mouse embryonic stem cell-derived oligodendrocytes in the murine model of globoid cell leukodystrophy.Potential of embryonic and adult stem cells in vitro.Effect of drugs in secondary disease progression in patients with multiple sclerosis.Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis.Phosphorylated olig1 localizes to the cytosol of oligodendrocytes and promotes membrane expansion and maturation.Focal Injection of Ethidium Bromide as a Simple Model to Study Cognitive Deficit and Its ImprovementNeurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis.Gliopathic pain: when satellite glial cells go badGlial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.TSC1/TSC2 signaling in the CNS.Enhancing remyelination in disease--can we wrap it up?An update on spinal cord injury research.Improving myelin/oligodendrocyte-related dysfunction: a new mechanism of antipsychotics in the treatment of schizophrenia?Longitudinal in vivo coherent anti-Stokes Raman scattering imaging of demyelination and remyelination in injured spinal cord.Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.The Effect of Levothyroxine on Serum Levels of Interleukin 10 and Interferon-gamma in Rat Model of Multiple Sclerosis.Haloperidol promotes proliferation but inhibits differentiation in rat oligodendrocyte progenitor cell cultures.Field potential recording from rat hippocampus provides a functional evaluation method for assessing demyelination and myelin repair.Perturbed myelination process of premyelinating oligodendrocyte in Niemann-Pick type C mouse.Thyroid hormone participates in the regulation of neural stem cells and oligodendrocyte precursor cells in the central nervous system of adult rat.Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.Ameliorating Effect of Osteopontin on H2O2-Induced Apoptosis of Human Oligodendrocyte Progenitor Cells.Achievements and obstacles of remyelinating therapies in multiple sclerosis.Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination.Basic fibroblast growth factor potentiates myelin repair following induction of experimental demyelination in adult mouse optic chiasm and nerves.Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.Complete blood count and acetylcholinesterase activity of lymphocytes of demyelinated and ovariectomized rats treated with resveratrol.Effects of Levothyroxine on Visual Evoked Potential Impairment Following Local Injections of Lysolecithin into the Rat Optic Chiasm.Dynamic Calcium Release From Endoplasmic Reticulum Mediated by Ryanodine Receptor 3 Is Crucial for Oligodendroglial Differentiation.
P2860
Q24799127-C33B4B44-0EFA-4E40-AB85-5FA36AC0D19CQ27022727-CB0252D8-31E5-45DB-BABF-14708888A90BQ28581342-D6AF72E7-78DC-4AF9-8135-C404D8FBB49CQ33957267-8CA90FC0-0E13-4F05-B4A5-D2A2663CFFF5Q34271973-879EC63C-B4C5-44B4-ADB4-DFABCE667A7CQ34695082-4E740357-59B1-4366-BC79-898304346154Q34996552-AE47F2C3-D8C1-4DD8-B576-64985590EAE0Q35058625-406D3A8A-FDA0-4848-A4F2-E344270CF5B5Q35094706-D9BCF301-2F62-482A-B662-1623C5A1608CQ35549843-1963FB63-4705-4654-9023-BB132A0622F7Q35605784-967D8859-B59B-484B-AF2C-3D72CD7331B0Q35818152-615F0662-A4FF-419B-82CA-9B350BD61D05Q36261669-BE47D3E7-66C9-4007-8D68-93FBF1AB7693Q36548289-B61101F4-F60E-4891-B2A6-B3F6EC674A17Q36966917-8A029946-484C-45F2-981C-031803DCD004Q37441914-0049D447-012A-4782-82F7-F3F1DF04F4B9Q37614111-8C8C5EEC-5089-4109-A4C0-4E3386B4725BQ37634375-A8A20159-C463-4C63-86D6-A758B3CB028CQ37844199-2DDEE45A-7B22-49DD-B6C5-D4ABD6BAB3FFQ37867334-E7D6E1FF-61A1-49E5-8E06-45327E29ED4EQ38057671-11AD60D2-FA04-411F-AC4C-5DC6C41CDBF5Q38060893-EF48B038-033D-4805-B3B6-4D571D58A57CQ38919410-1AE8E375-0ED6-402A-9706-9D30BD3FD57BQ41812779-2B3E49EA-C305-4794-8034-33940DC6AB3DQ42280869-0DA39BA4-B26A-4118-94E4-6A8FB8EE39F5Q42961696-A3C351FC-6A1E-4723-B670-ADAB9895CC6FQ43489900-F9D8C730-C938-45C2-8C09-A5C3120298A1Q44951309-842F9873-A212-472E-86A5-900A12F08EE2Q45079468-0CB6B305-96C0-439E-AAFE-14E4C8221BA4Q46528181-4D401D3E-270E-4782-84F7-0AAC9FBED07FQ47645324-D5BBF7B3-B3F8-4DAC-BD2A-7970043EB277Q47835493-B61F981B-DC10-467A-8EA8-2154C38409B5Q48228228-7F6DF9C5-6C8D-4923-BE85-5B7880BD522CQ48535525-99EEF2E5-D4A8-4785-B3F2-55CD1B1D71FAQ50463666-6AEC1333-8E95-46A2-B9A3-088C35890A0CQ51342169-29AA3A21-8E03-4C2C-8F6D-BB8EA7180A4CQ55263092-2112D3A5-33E9-4548-85E1-0E75F231234FQ55359989-819D8349-C26D-4E0D-9B9A-75C5B2C6A6C3
P2860
Remyelinating strategies for the treatment of multiple sclerosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Remyelinating strategies for the treatment of multiple sclerosis.
@en
type
label
Remyelinating strategies for the treatment of multiple sclerosis.
@en
prefLabel
Remyelinating strategies for the treatment of multiple sclerosis.
@en
P1476
Remyelinating strategies for the treatment of multiple sclerosis.
@en
P2093
Martin Stangel
P304
P356
10.1016/S0301-0082(02)00105-3
P577
2002-12-01T00:00:00Z